JP2015509705A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015509705A5 JP2015509705A5 JP2014551570A JP2014551570A JP2015509705A5 JP 2015509705 A5 JP2015509705 A5 JP 2015509705A5 JP 2014551570 A JP2014551570 A JP 2014551570A JP 2014551570 A JP2014551570 A JP 2014551570A JP 2015509705 A5 JP2015509705 A5 JP 2015509705A5
- Authority
- JP
- Japan
- Prior art keywords
- absent
- seq
- nucleic acid
- acid molecule
- nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12000106 | 2012-01-10 | ||
| EPPCT/EP2012/000089 | 2012-01-10 | ||
| PCT/EP2012/000089 WO2012095303A1 (en) | 2011-01-10 | 2012-01-10 | Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same |
| EP12000106.0 | 2012-01-10 | ||
| EP12006960 | 2012-10-08 | ||
| EP12006960.4 | 2012-10-08 | ||
| PCT/EP2013/000056 WO2013104540A1 (en) | 2012-01-10 | 2013-01-10 | New c5a binding nucleic acids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015509705A JP2015509705A (ja) | 2015-04-02 |
| JP2015509705A5 true JP2015509705A5 (cg-RX-API-DMAC7.html) | 2016-03-03 |
| JP6415327B2 JP6415327B2 (ja) | 2018-10-31 |
Family
ID=48781063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014551570A Active JP6415327B2 (ja) | 2012-01-10 | 2013-01-10 | 新規なｃ５ａ結合性核酸 |
Country Status (18)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015066027A2 (en) | 2013-10-28 | 2015-05-07 | Dots Devices, Inc. | Allergen detection |
| WO2015103438A2 (en) | 2014-01-02 | 2015-07-09 | Genelux Corporation | Oncolytic virus adjunct therapy with agents that increase virus infectivity |
| US11172873B2 (en) | 2018-05-17 | 2021-11-16 | The Procter & Gamble Company | Systems and methods for hair analysis |
| WO2019222340A1 (en) | 2018-05-17 | 2019-11-21 | The Procter & Gamble Company | Systems and methods for hair coverage analysis |
| EP3586865A1 (en) * | 2018-06-21 | 2020-01-01 | Charité - Universitätsmedizin Berlin | Complement anaphylatoxin binders and their use in treatment of a subject having an ocular wound and/or fibrosis |
| EP3814504A1 (en) | 2018-06-29 | 2021-05-05 | The Procter & Gamble Company | Aptamers for personal care applications |
| JP2022512969A (ja) * | 2018-11-12 | 2022-02-07 | アプタリオン バイオテック エージー | Ｃｘｃｌ８結合核酸 |
| MX2021012433A (es) | 2019-04-16 | 2021-11-17 | Procter & Gamble | Aptameros para aplicaciones para el control de olor. |
| US12039732B2 (en) | 2021-04-14 | 2024-07-16 | The Procter & Gamble Company | Digital imaging and learning systems and methods for analyzing pixel data of a scalp region of a users scalp to generate one or more user-specific scalp classifications |
| CN113150106B (zh) * | 2021-04-26 | 2022-08-16 | 华中农业大学 | 来源于补体成分C5a的抗菌肽及其应用 |
| EP4620474A1 (en) | 2024-03-20 | 2025-09-24 | APTARION biotech AG | Method of treating a disorder with a c5a inhibitor |
| WO2025196240A1 (en) | 2024-03-20 | 2025-09-25 | Aptarion Biotech Ag | Method of treating a disorder with a c5a inhibitor |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6140490A (en) | 1996-02-01 | 2000-10-31 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands of complement system proteins |
| US6011020A (en) | 1990-06-11 | 2000-01-04 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand complexes |
| US6395888B1 (en) | 1996-02-01 | 2002-05-28 | Gilead Sciences, Inc. | High affinity nucleic acid ligands of complement system proteins |
| US6395029B1 (en) | 1999-01-19 | 2002-05-28 | The Children's Hospital Of Philadelphia | Sustained delivery of polyionic bioactive agents |
| US6652886B2 (en) | 2001-02-16 | 2003-11-25 | Expression Genetics | Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents |
| EP1306382A1 (de) | 2001-10-26 | 2003-05-02 | Noxxon Pharma AG | Modifizierte L-Nukleinsäure |
| DK1438321T5 (da) | 2001-10-26 | 2011-02-21 | Noxxon Pharma Ag | Modificeret L-nukleinsyre |
| EP2138575B8 (en) | 2002-02-20 | 2013-07-24 | Mersana Therapeutics, Inc. | Conjugates comprising a biodegradable polymer and uses therefor |
| FI20051017A7 (fi) | 2003-04-13 | 2005-11-28 | Enzon Pharmaceutivals Inc | Polymeeriset oligonukleotidiaihiolääkkeet |
| GB0314472D0 (en) | 2003-06-20 | 2003-07-23 | Warwick Effect Polymers Ltd | Polymer |
| US20070116710A1 (en) | 2004-02-03 | 2007-05-24 | Leonard Bell | Methods of treating hemolytic anemia |
| EP1713509A2 (de) | 2004-02-09 | 2006-10-25 | Noxxon Pharma AG | Verfahren zur herstellung von konjugaten aus polysacchariden und polynukleotiden |
| EP2578683B9 (en) * | 2004-02-12 | 2015-04-15 | Archemix LLC | Aptamer therapeutics useful in the treatment of complement-related disorders |
| US7803931B2 (en) | 2004-02-12 | 2010-09-28 | Archemix Corp. | Aptamer therapeutics useful in the treatment of complement-related disorders |
| AU2005232371B2 (en) | 2004-03-23 | 2010-10-14 | Complex Biosystems Gmbh | Polymeric prodrug with a self-immolative linker |
| EP1807092B1 (en) | 2004-11-05 | 2016-09-07 | The Children's Hospital of Philadelphia | Biodegradable linkers for molecular therapies |
| JP2008526915A (ja) * | 2005-01-17 | 2008-07-24 | イエリニ・アクチェンゲゼルシャフト | Ｃ５ａ受容体アンタゴニスト |
| CN104623692A (zh) | 2006-03-08 | 2015-05-20 | 阿切埃米克斯股份有限公司 | 治疗视觉失调中使用的补体结合适体和抗-c5药物 |
| EP2063709A2 (en) | 2006-09-15 | 2009-06-03 | Enzon Pharmaceuticals, Inc. | Hindered ester-based biodegradable linkers for oligonucleotide delivery |
| EP2061901A2 (en) | 2006-10-31 | 2009-05-27 | Noxxon Pharma AG | Methods for detection of a single- or double-stranded nucleic acid molecule |
| AU2008303775A1 (en) | 2007-09-24 | 2009-04-02 | Noxxon Pharma Ag | C5a binding nucleic acids |
| JP4642940B2 (ja) | 2009-03-11 | 2011-03-02 | オリンパスメディカルシステムズ株式会社 | 画像処理システム、その外部装置およびその画像処理方法 |
| US20120065254A1 (en) | 2009-03-23 | 2012-03-15 | Noxxon Pharma Ag | C5A binding nucleic acids and the use thereof |
| EP2561079A1 (en) | 2010-04-21 | 2013-02-27 | Noxxon Pharma AG | Lipid binding nucleic acids |
| EP2663640B1 (en) * | 2011-01-10 | 2020-11-04 | APTARION biotech AG | Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same |
| SG11201401362TA (en) | 2011-10-21 | 2014-05-29 | Noxxon Pharma Ag | Glucagon binding nucleic acids |
| KR20140111704A (ko) | 2012-01-10 | 2014-09-19 | 녹손 파르마 아게 | Cgrp에 특이적으로 결합하는 핵산 |
-
2013
- 2013-01-10 PT PT137006177T patent/PT2802660T/pt unknown
- 2013-01-10 KR KR1020147022321A patent/KR102034203B1/ko active Active
- 2013-01-10 JP JP2014551570A patent/JP6415327B2/ja active Active
- 2013-01-10 AU AU2013209131A patent/AU2013209131A1/en not_active Abandoned
- 2013-01-10 CA CA2860806A patent/CA2860806C/en active Active
- 2013-01-10 PL PL13700617T patent/PL2802660T3/pl unknown
- 2013-01-10 MX MX2014008454A patent/MX362061B/es active IP Right Grant
- 2013-01-10 DK DK13700617.7T patent/DK2802660T3/da active
- 2013-01-10 US US14/371,006 patent/US9518265B2/en active Active
- 2013-01-10 CN CN201380009020.9A patent/CN104145018B/zh active Active
- 2013-01-10 SG SG10201605594UA patent/SG10201605594UA/en unknown
- 2013-01-10 ES ES13700617T patent/ES2786007T3/es active Active
- 2013-01-10 SG SG11201403771SA patent/SG11201403771SA/en unknown
- 2013-01-10 WO PCT/EP2013/000056 patent/WO2013104540A1/en not_active Ceased
- 2013-01-10 EP EP13700617.7A patent/EP2802660B1/en active Active
- 2013-01-10 RU RU2014132708A patent/RU2645261C2/ru active
- 2013-01-10 BR BR112014016877-6A patent/BR112014016877B1/pt active IP Right Grant
- 2013-01-10 IN IN5665DEN2014 patent/IN2014DN05665A/en unknown
-
2014
- 2014-07-03 IL IL233516A patent/IL233516B/en active IP Right Grant
-
2016
- 2016-12-12 US US15/376,338 patent/US10590424B2/en active Active
-
2018
- 2018-11-30 AU AU2018271388A patent/AU2018271388B2/en active Active
-
2020
- 2020-03-15 US US16/819,102 patent/US11492625B2/en active Active
-
2022
- 2022-11-07 US US17/982,469 patent/US12188021B2/en active Active
-
2025
- 2025-01-05 US US19/010,141 patent/US20250327082A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015509705A5 (cg-RX-API-DMAC7.html) | ||
| RU2014132708A (ru) | НОВЫЕ СВЯЗЫВАЮЩИЕ C5a НУКЛЕИНОВЫЕ КИСЛОТЫ | |
| Zeisberg et al. | Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis | |
| JP2022017333A5 (cg-RX-API-DMAC7.html) | ||
| RU2010116245A (ru) | НУКЛЕИНОВЫЕ КИСЛОТЫ, СВЯЗЫВАЮЩИЕ C5a | |
| US11904057B2 (en) | Nanoparticle-hydrogel composite for nucleic acid molecule delivery | |
| AU2012257774B2 (en) | High-affinity, dimeric inhibitors of PSD-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain | |
| JP2013524792A5 (cg-RX-API-DMAC7.html) | ||
| JP2006513724A5 (cg-RX-API-DMAC7.html) | ||
| US20080305073A1 (en) | Therapeutic Agents for the Treatment of Hmgb1-Related Pathologies | |
| JP2010539893A5 (cg-RX-API-DMAC7.html) | ||
| JP2012525124A5 (cg-RX-API-DMAC7.html) | ||
| JP2008504335A5 (cg-RX-API-DMAC7.html) | ||
| CN104450691A (zh) | 结合海帕西啶的核酸 | |
| CN103502262A (zh) | 基于双头两亲性肽的自组装水凝胶 | |
| JP2014533098A5 (cg-RX-API-DMAC7.html) | ||
| CN103012562A (zh) | 一种双重靶向的d构型多肽及其递药系统 | |
| RU2014132706A (ru) | Нуклеиновые кислоты, специфически связывающие cgrp | |
| JP2021073179A (ja) | アポトーシスを誘導するための組成物及び方法 | |
| CN106868009A (zh) | 一种用于检测妇科慢性盆腔炎的试剂盒及其检测方法 | |
| WO2019096095A1 (zh) | 整合素受体靶向的抗癌偶联物 | |
| JP2020513192A (ja) | 低分子ｒｎａ、並びに線維増殖性疾患及び／又は症候群の予防及び／又は治療におけるその応用 | |
| US20160032057A1 (en) | Novel pi polyamide | |
| JP6479331B2 (ja) | 脊髄組織標的化ペプチド及びその利用 | |
| WO2013033658A1 (en) | Self-assembled nanostructures |